🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Hyperglycemic clamp procedure

Found 26 matching trials

Identification of β Cell Dysfunction in Relatives of Individuals With Type 1 Diabetes Mellitus

N/A

Despite the valuable information derived from older studies evaluating type...

Status

Completed

Location

Indiana University

Start Date

2017-11-14

Trial ID

NCT04362917

Treatments Being Tested

There is no intervention

Insulin Secretion in Diabetes Before and After Glycemic Control

The objective of this project is to understand defects in insulin secretion...

Status

Completed

Location

VA Medical Center, Cincinnati

Start Date

2008-04

Trial ID

NCT00469833

Treatments Being Tested

insulin glargine

Glucose Clamp Study to Prove Hypo- and Hyperglycemic Episodes Using a Non-invasive Glucose Monitoring Device

PHASE1

Continuous monitoring of the skin tissue glucose concentration on two diffe...

Status

Completed

Location

Profil Institut für Stoffwechselforschung GmbH

Start Date

2003-01

Trial ID

NCT01060917

Treatments Being Tested

Non-invasive CGMS (continuous glucose monitoring system)Hyperglycemic and hypoglycemic glucose clamp Non-invasive CGMS (GlucoDay)

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

N/A

This clinical research studies the physiology and immunology of new-onset p...

Status

Unknown

Location

Vanderbilt University Medical Center

Start Date

2019-03-12

Trial ID

NCT03415139

Treatments Being Tested

Oral Glucose Tolerance Test (OGTT)2 OGTTs with and without GLP-1 analogue Hyperglycemic clamp procedure

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

PHASE1

In patients with type 2 diabetes, the incretin hormone glucose-dependent in...

Status

Completed

Location

Multiple Locations

Start Date

2004-05

Trial ID

NCT02673554

Treatments Being Tested

GIP Bolus GIP Clamp Oral glucose tolerance test (OGTT)hyperglycemic clamp

Alpelisib Challenge Test (ACT)

PHASE1

The goal of this study is to test a potentially easier method for measuring...

Status

Not Yet Recruiting

Location

Columbia University Irving Medical Center

Start Date

2026-09-01

Trial ID

NCT07778524

Treatments Being Tested

Alpelisib 300 mg Alpelisib Challenge Test (ACT): Mixed Meal Tolerance Test (MMTT) after taking alpelisib Hyperglycemic clamp

Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance

Experimental results are strongly suggesting that PCSK9 and FXR could occur...

Status

Completed

Location

CHU de Nantes

Start Date

2008-02

Trial ID

NCT00422006

Treatments Being Tested

biopsy of muscle, of liver, and of adipose tissue clamp euglycemic - hyperglycemic diet biopsies for biological and genetic analyses

Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis

PHASE4

The purpose of this study is to determine the effect of chronic PDE5 inhibi...

Status

Terminated

Location

Vanderbilt University

Start Date

2011-08

Trial ID

NCT01409993

Treatments Being Tested

Sildenafil Placebo Hyperglycemic clamp Euglycemic clamp

Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.

PHASE1

Glucagon secretion from α-cells has long been viewed as primarily a counter...

Status

Recruiting

Location

Duke Center for Living

Start Date

2025-12-30

Trial ID

NCT07224334

Treatments Being Tested

Exendin-9 is a 30 amino acid peptide that is an established competitive antagonist of the GLP-1 receptor. Subjects will receive exendin-9 by intravenous infusion at a rate of 600 pmol/kg/min Dexamethasone

Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

PHASE1

This is a clinical study of a drug named dopamine and how it affects our bo...

Status

Completed

Location

Montefiore Medical Center of Albert Einstein College of Medicine

Start Date

2013-12

Trial ID

NCT02053935

Treatments Being Tested

Dopamine

Previous Next